Last Price
215.65
Today's Change
-0.75 (0.34%)
Day's Change
213.23 - 216.50
Trading Volume
756,741
Market Cap
104 Billion
Shares Outstanding
484 Million
Avg Volume
962,418
Avg Price (50 Days)
250.73
Avg Price (200 Days)
258.26
PE Ratio
22.70
EPS
9.50
Earnings Announcement
08-Feb-2026
Previous Close
216.40
Open
216.00
Day's Range
213.23 - 216.5
Year Range
208.35 - 310.0
Trading Volume
757,097
1 Day Change
-0.33%
5 Day Change
-1.96%
1 Month Change
-19.50%
3 Month Change
-12.70%
6 Month Change
-18.56%
Ytd Change
-23.29%
1 Year Change
-30.27%
3 Year Change
-27.01%
5 Year Change
-25.88%
10 Year Change
138.58%
Max Change
25990.22%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
{uid}
{comment}
Just now